Support for COVID19 Patients at Home (Mirato)

Istituti Clinici Scientifici Maugeri SpA

Status: Completed

Conditions: COVID19 Patients

Treatments: Other: Telecare Group; Other: Control group

Study type: Observational

Funder types: Other

Identifiers

NCT04898179

ICS Maugeri CE2455

Details and patient eligibility

About

The rapid spread and increase of acute respiratory infection cases caused by the novel SARS-CoV-2 coronavirus represent a major challenge for healthcare systems around the world. The shortage of facilities and medical personnel is a major problem in the face of a serious epidemic. The Lombardy Region, and in particular the territories of Milan, Bergamo and Brescia, was the most affected due to the rapid increase in cases and limited medical resources during the initial phase of the epidemic.

The collaboration between hospital and territory with integrated communication systems and the monitoring of patients with appropriate technological tools that include telemedicine, are fundamental to ensure the continuity of care and the sustainability of the health system, also significantly reducing the risk of contagion for health professionals.

Full description

The MIRATO Project wants to test the remote health surveillance services and a telemonitoring program for patients discharged after a period of hospitalization for COVID19 caused by the new coronavirus SARS-CoV-2 and their comorbidities if present.

Patients discharged from hospitals still present in many cases breathing difficulties, bed rest symptoms and other disabilities related to the acute event. In addition, some patients are seeing rekindling of symptoms such as fever, dry cough, difficulty respiratory and blood desaturation into oxygen. These problems underline the need for procedures that allow us to safely discharge patients to be able to better follow their convalescence but also to be able to intervene quickly in the event of symptoms returning.

The purpose of the home health surveillance intervention will be:

• Monitor the evolution of the state of health with standardized tools based on scientific evidence
• Provide counselling support to help recovery
• Have certain and early identification of signs and symptoms related to a possible resumption of the COVID19 pathology and or to comorbidities
• Compare outcome results with case-control design three months after hospital discharge

Enrollment: 796 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalisation for COVID19
• Patients discharged at home

Exclusion criteria

• Patient refusal
• Patients discharged at a nursing home

Trial design

796 participants in 2 patient groups

Telecare group

Description:

When discharged, patients will be followed at home by a telecare nursing and specialist teleconsultation program for 3 months. The key element of the program will be a structured nurse-managed telephone support and, when necessary, video consultations, to follow patients, for the first month. During these contacts, the nurse will conduct a standardized interview enquiring about the general clinical condition of the patient. In the case of any symptom or problem, the patient will be able to call the service. At the end of the third month, patients will contact again to check their clinical condition and to close the program. Patients will be provided with a pulse oximeter to measure O2 saturation. At the start and end of the program, patients were administered the SF-12 quality of life questionnaire.

Treatment:

Other: Telecare Group

Control group

Description:

The patients in the control group will be followed by their general practitioner and they will be contacted after three months to check their clinical condition.

Treatment:

Other: Control group